Morgan Stanley’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Morgan Stanley’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-75	Closed	-$9K	–	6655
2016 Q3	$9K	Hold	75	–	–	﹤0.01%	6144
2016 Q2	$11K	Hold	75	–	–	﹤0.01%	6053
2016 Q1	$11K	Buy	+75	New	+$10.1K	﹤0.01%	6121

Morgan Stanley's AMSGP Position: Q4 2016 in Review

Morgan Stanley sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 75 shares — an estimated $9K sold.

Morgan Stanley first reported a position in AMSGP in Q1 2016 and held it in 3 quarters. The position peaked at $11K in Q2 2016. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

Morgan Stanley reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
Morgan Stanley sold 75 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $9K.
Morgan Stanley first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q1 2016 and held it in 3 quarters.
Morgan Stanley's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $11K in Q2 2016.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.